Poongjeon Pharmacy풍전약품
298060 · KOSDAQ · ₩298060 · 풍전약품
₩2,375▲ ₩5 (0.21%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 29.4% | 55.1% | 39.6% | 48.7% | 44.4% | 79.2% |
| Operating margin | −15.9% | −128.3% | −1,371.0% | −1,868.3% | −3,176.6% | −2,767.2% |
| Net margin | −19.2% | −47.8% | −1,500.6% | −3,444.2% | −5,790.7% | −5,126.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +716.7% | +340.2% | +18.6% | +75.7% | −9.9% | — |
| Operating income growth | −1.2% | +58.8% | +13.0% | −3.3% | −3.5% | — |
| Net income growth | −227.4% | +86.0% | +48.3% | −4.5% | −1.8% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −17.2% | −7.2% | −71.4% | −106.5% | −66.3% | −50.5% |
| Return on assets | −12.6% | −5.3% | −51.0% | −82.0% | −52.7% | −41.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 48.7% | 24.4% | 63.4% | 24.1% | 34.7% | 21.1% |
| Net debt to equity | −20.8% | −23.6% | 41.3% | −42.5% | −5.2% | 6.6% |
| Current ratio | 222.9% | 209.8% | 34.8% | 1,154.8% | 220.1% | 233.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Poongjeon Pharmacy / 풍전약품 / 298060 / KRX:298060
Source: KRX statistical information